ALLO-329
ALLO-329-101
Phase 1 gene_therapy active
Quick answer
ALLO-329 for Systemic Lupus Erythematosus (With and Without Nephritis) is a Phase 1 program (gene_therapy) at Allogene Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allogene Therapeutics
- Indication
- Systemic Lupus Erythematosus (With and Without Nephritis)
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active